DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Masuzaki H, Flier JS.
Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)-a promising drug target for the treatment of metabolic syndrome.
Curr Drug Targets Immune Endocr Metabol Disord 2003; 3: 255-262
We do not assume any responsibility for the contents of the web pages of other providers.